2NCCL (EP 5-T2). Precision performance of clinical chemistry devices second edition;Tentative guideline.[K]. 1992.
3NCCL (EP 9-P). User comparison of quantitative clinical laboratory using patient samples; Proposed Guideling[K]. 1986.
4Pearson TA,Criqui MH,Luepha RV, et al.Primer inpreventive cardiology[]..1994
5Li JZ,Chen WX,Wang S,et al.Long-term biologicalvariability of serum lipids[].Chinese Journal of Laboratory Medicine.2002
6Li JZ,Niu QT,Wang S,et al.Variation of serum lipids,lipoproteins and apolipoproteins in the elderly[].Chin J GeriatrMed (Chin).1990
7Weverling-Rijnsburger AW,Blauw GJ,Lagaay AM,et al.Total cholesterol and risk of mortality in the oldest old[].The Lancet.1997
8Grundy S M,Cleeman J I,Rifkind B M,et al.Cholesterol lowering in the elderly population[].Archives of Internal Medicine.1999
9Cleeman JT.Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)[].Journal of the American Medical Association The.2001
10Li JZ.Serum lipids (In: Geriatrics progress of China in recent 50 years)[].Chin J Geriatr Med (Chin).1989
